Global: Pharmaceuticals Industry Guide

Published Date: 28/03/2011
Category: Therapies & Markets

Research Report Decription

Sample Pages:

Click here (PDF)

Global: Pharmaceuticals Industry Guide is an essential resource for top-level data and analysis covering the Global Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, Life Sciences Tools & Services, OTC Pharmaceuticals, Pharmaceuticals and Pharmaceuticals, Biotechnology & Life Sciences.

• Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, Life Sciences Tools & Services, OTC Pharmaceuticals, Pharmaceuticals and Pharmaceuticals, Biotechnology & Life Sciences
• Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
• Incorporates in-depth five forces competitive environment analysis and scorecards
• Includes five-year forecasts for Biotechnology, Generics, Life Sciences Tools & Services, OTC Pharmaceuticals, Pharmaceuticals and Pharmaceuticals, Biotechnology & Life Sciences

Key Questions Answered:

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

Companies Mentioned:

Merck & Co., Novartis AG, Pfizer, Sanofi-Aventis SA

Paper Highlights:

• The global biotechnology market had total revenue of $200 billion in 2009, representing a compound annual growth rate (CAGR) of 10.2% for the period spanning 2005-2009.
• The global generics market had total revenue of $149.7 billion in 2009, representing a compound annual growth rate (CAGR) of 11% for the period spanning 2005-2009.
• The global life sciences tools and services market generated total revenues of $18.1 billion in 2009, representing a compound annual growth rate (CAGR) of 10.5% for the period spanning 2005-2009.
• The global OTC pharmaceuticals market generated total revenues of $110.7 billion in 2009, representing a compound annual growth rate (CAGR) of 3.9% for the period spanning 2005-2009.
• The global pharmaceuticals market is expected to have total revenue of $693 billion in 2010, representing a compound annual growth rate (CAGR) of 4.8% for the period spanning 2006-2010.
• The global pharmaceuticals, biotechnology, and life sciences industry group generated total revenues of $1,071.7 billion in 2009, representing a compound annual growth rate (CAGR) of 6.7% for the period spanning 2005-2009.